Skip to main content

US ClosedU.S. Closed

DRUG: Bright Minds Biosciences Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Bright Minds Biosciences Inc. , a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States.

52W Range

41stpctl

Volume

0.40×avg

Market Cap

712.60MUSD

P/E Ratio

-35.0TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Bright Minds Biosciences Inc.

DRUGNASDAQ·USD·Closed

Bright Minds Biosciences Inc.

DRUGNASDAQ·USD·Closed

$72.81

−2.31%

$72.81

−$1.72 (2.31%)

52W Range

41stpctl

Volume

0.40×avg

Mkt Cap

712.60MUSD

P/E

-35.0TTM

Div Yield

–ann